Information only — not investment advice; no trading here. Every number shows when it was observed and where it came from; stale sources are labelled as stale.

BMRA BIOMERICA INC

equity · exchange Nasdaq · CIK 0000073290 · trades in USD

AI brief AI-written, not reviewed by a person

Latest figures show BMRA's cash and equivalents at 2.733 million USD as of 2026-08-31, up from 1.308 million USD on 2026-05-31 and 1.336 million USD on 2026-02-28. Diluted EPS (year) for 12 months to 2026-05-31 is -1.3 USD per share, compared with -2.16 USD per share for the year to 2025-05-31. Stockholders’ equity stood at 3.648 million USD as of 2026-08-31, versus 2.630 million USD on 2026-05-31 and 3.317 million USD on 2026-02-28.

Written by OpenVibe.AI from the SEC numbers and filings on this page, not reviewed by a person. Informational only; not investment advice. Written from figures and filings up to (gpt-5-nano-2025-08-07).

What the sources did not support
  • No data from sources after 2026-08-31 beyond those cited; some figures (e.g., quarterly metrics) not harmonized to the same period as the yearly data in the summary.

Observations

Latest observation per metric. Values are exactly as the source stated them.
MetricValueObservedSourceRetrievedFreshness
Revenue (quarter) (3 months to 2026-08-31) 1,265,000 USD sec-companyfacts current
Revenue (year) (12 months to 2026-05-31) 4,453,000 USD sec-companyfacts current
Net income (quarter) (3 months to 2026-08-31) -1,232,000 USD sec-companyfacts current
Net income (year) (12 months to 2026-05-31) -3,775,000 USD sec-companyfacts current
Operating income (quarter) (3 months to 2026-08-31) -1,227,000 USD sec-companyfacts current
Operating income (year) (12 months to 2026-05-31) -5,320,000 USD sec-companyfacts current
Diluted EPS (quarter) (3 months to 2026-08-31) -0.37 USD/shares sec-companyfacts current
Diluted EPS (year) (12 months to 2026-05-31) -1.3 USD/shares sec-companyfacts current
Operating cash flow (quarter) (3 months to 2026-08-31) -802,000 USD sec-companyfacts current
Operating cash flow (year) (12 months to 2026-05-31) -3,421,000 USD sec-companyfacts current
Total assets (at 2026-08-31) 8,071,000 USD sec-companyfacts current
Total liabilities (at 2026-08-31) 4,423,000 USD sec-companyfacts current
Stockholders' equity (at 2026-08-31) 3,648,000 USD sec-companyfacts current
Cash and equivalents (at 2026-08-31) 2,733,000 USD sec-companyfacts current
Shares outstanding (at 2026-09-28) 4,598,968 shares sec-companyfacts current

Context

No reviewed context has been published for BMRA. The observations and documents below are shown as their sources stated them.

Documents

Feeds of BMRA documents: RSS · Atom · JSON Feed

Source freshness

Sources behind this page. A source is stale when its last successful fetch is older than its window.
SourceFreshnessLast successful fetchStale afterSources reports
SEC EDGAR: company financial facts (XBRL) sec-companyfacts current 10080 min ok
SEC EDGAR: latest XBRL filings sec-xbrl-filings current 45 min healthy

Watch this instrument

Sign in to add BMRA to a private watchlist or to get an alert when a new document or observation arrives.

Machine-readable: BMRA.json (the same data with every timestamp and source).

Information only — not investment advice; no trading here. OpenVibe.Trade holds no money or assets, takes no orders and gives no personal recommendations.